Whitepaper: Neuroinflammation study
Posted: 15 July 2020 | Ncardia | No comments yet
Neuroinflammation study by combining human iPSC-derived astrocytes and HTRF.
Activated astrocytes that release pro-inflammatory factors have been reported in neurodegenerative diseases. Monitoring neuroinflammation is important for further development of therapeutic treatments. Here we describe how hiPSC-derived astrocytes in combination with HTRF cellular assays offer a robust and physiologically relevant solution to study neuroinflammation pathways.
Related content from this organisation
- Investigating the promising future of organoids
- Whitepaper: Advancing drug discovery for neurodegenerative diseases
- Right model, right complexity: using in vitro human disease cell models in drug discovery
- Targeting tau – chasing a treatment for Alzheimer’s
- Cellistic and Celyad Oncology announce GMP cell therapy manufacturing operations transaction
Related topics
Hit-to-Lead, Imaging, Screening, Stem Cells, Targets
Related organisations
Ncardia
